Revisiting Systemic Thrombolysis in Acute Pulmonary Embolism
- PMID: 38939641
- PMCID: PMC11198091
- DOI: 10.1016/j.jacadv.2024.100923
Revisiting Systemic Thrombolysis in Acute Pulmonary Embolism
Keywords: aspiration devices; pulmonary embolism; systemic thrombolysis.
Conflict of interest statement
Dr Rozenbaum has received a consultant fee from Angiodynamics.
Figures
References
-
- Meyer G., Vicaut E., Danays T., et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370:1402–1411. - PubMed
-
- Konstantinides S.V., Vicaut E., Danays T., et al. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol. 2017;69:1536–1544. - PubMed
-
- Nakamura S., Takano H., Kubota Y., Asai K., Shimizu W. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis. J Thromb Haemost. 2014;12:1086–1095. - PubMed
-
- Chatterjee S., Chakraborty A., Weinberg I., et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014;311:2414–2421. - PubMed
-
- Pruszczyk P., Klok F.A., Kucher N., et al. Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of percutaneous Cardiovascular Interventions. EuroIntervention. 2022;18:e623–e638. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
